TP53 and hepatocellular carcinoma: This hypothesis is supported by several reports showing that gene-signatures, including those centred about altered HCC-associated interferon (IFN)-γ and p53 signaling networks, in non-tumour tissue can be measured as an indicator for the probability of recurrence [56,57,58].